US Patent Issued to BioAegis Therapeutics on Sept. 1 for "Methods and compositions for treating frailty" (American, Finnish Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,721,880, issued on Sept. 1, was assigned to BioAegis Therapeutics Inc. (Morristown, N.J.).

"Methods and compositions for treating frailty" was invented by Thomas P. Stossel (Morristown, N.J.) and Timo E. Strandberg (Helsinki).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to the assessment of frailty conditions and methods of using gelsolin to treat frailty conditions."

The patent was filed on May 3, 2021, under Application No. 17/923,168.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G...